Expression of TGF-β1, TβRII and Smad4 in colorectal carcinoma

Experimental and Molecular Pathology

Volumn 82, Issue 3, 2007, Pages 284-291

  Xu, Wei Qing ^a   Jiang, Xu Cheng ^a   Zheng, Lin ^a   Yu, Yin Yan ^a   Tang, Jian Min ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Second Medical University School of Stomatology   (China)

Author keywords

Colorectal carcinoma; Immunohistochemistry; In situ hybridization; Smad4; T RII; TGF 1

Indexed keywords

SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; MESSENGER RNA; SMAD4 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER TISSUE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE COURSE; METABOLISM; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY;

COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEOPLASM METASTASIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL;

EID: 34247579681     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.10.011     Document Type: Article

References (35)

1. Akhurst R.J., and Balmain A. Genetic events and the role of TGF beta in epithelial tumour progression. J. Pathol. 187 (1999) 82-90
2. Dai J.L., Schutte M., Bansal R.K., Wilentz R.E., Sugar A.Y., and Kern S.E. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Mol. Carcinog. 26 (1999) 37-43
3. Grady W.M., Myeroff L.L., Swinler S.E., Rajput A., Thiagalingam S., Lutterbaugh J.D., Neumann A., Brattain M.G., Chang J., Kim S.J., Kinzler K.W., Vogelstein B., Willson J.K., and Markowitz S. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 59 (1999) 320-324
4. Hahn S.A., Hoque A.T., Moskaluk C.A., da Costa L.T., Schutte M., Rozenblum E., Seymour A.B., Weinstein C.L., Yeo C.J., Hruban R.H., and Kern S.E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56 (1996) 490-494
5. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., and Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 (1996) 350-353
6. Hocevar B.A., Brown T.L., and Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18 (1999) 1345-1356
7. Howe J.R., Roth S., Ringold J.C., Summers R.W., Jarvinen H.J., Sistonen P., Tomlinson I.P., Houlston R.S., Bevan S., Mitros F.A., Stone E.M., and Aaltonen L.A. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998) 1086-1088
8. Izumoto S., Arita N., Ohnishi T., Hiraga S., Taki T., Tomita N., Ohue M., and Hayakawa T. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. Cancer Lett. 112 (1997) 251-256
9. Kim S.J., Im Y.H., Markowitz S.D., and Bang Y.J. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis. Cytokine Growth Factor Rev. 11 (2000) 159-168
10. Koyama M., Ito M., Nagai H., Emi M., and Moriyama Y. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat. Res. 406 (1999) 71-77
11. Lu S.L., Zhang W.C., Akiyama Y., Nomizu T., and Yuasa Y. Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res. 56 (1996) 4595-4598
12. MacGrogan D., Pegram M., Slamon D., and Bookstein R. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15 (1997) 1111-1114
13. Maehara Y., Kakeji Y., Kabashima A., Emi Y., Watanabe A., Akazawa K., Baba H., Kohnoe S., and Sugimachi K. Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J. Clin. Oncol. 17 (1999) 607-614
14. Maitra A., Molberg K., Albores-Saavedra J., and Lindberg G. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am. J. Pathol. 157 (2000) 1105-1111
15. Manning A.M., Williams A.C., Game S.M., and Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene 6 (1991) 1471-1476
16. Markowitz S.D., and Roberts A.B. Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev. 7 (1996) 93-102
17. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., and Vogelstein B. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 (1995) 1336-1338
18. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
19. Matsushita M., Matsuzaki K., Date M., Watanabe T., Shibano K., Nakagawa T., Yanagitani S., Amoh Y., Takemoto H., Ogata N., Yamamoto C., Kubota Y., Seki T., Inokuchi H., Nishizawa M., Takada H., Sawamura T., Okamura A., and Inoue K. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br. J. Cancer 80 (1999) 194-205
20. Miyaki M., Iijima T., Konishi M., Sakai K., Ishii A., Yasuno M., Hishima T., Koike M., Shitara N., Iwama T., Utsunomiya J., Kuroki T., and Mori T. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18 (1999) 3098-3103
21. Moustakas A., Pardali K., Gaal A., and Heldin C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 82 (2002) 85-91
22. Ohue M., Tomita N., Monden T., Miyoshi Y., Ohnishi T., Izawa H., Kawabata Y., Sasaki M., Sekimoto M., Nishisho I., and Shiozaki H. Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer. Int. J. Cancer 68 (1996) 203-206
23. Piek E., Heldin C.H., and Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 13 (1999) 2105-2124
24. Robson H., Anderson E., James R.D., and Schofield P.F. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br. J. Cancer 74 (1996) 753-758
25. Serra R., and Moses H.L. Tumor suppressor genes in the TGF-beta signaling pathway?. Nat. Med. 2 (1996) 390-391
26. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
27. Takagi Y., Kohmura H., Futamura M., Kida H., Tanemura H., Shimokawa K., and Saji S. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111 (1996) 1369-1372
28. Takaku K., Oshima M., Miyoshi H., Matsui M., Seldin M.F., and Taketo M.M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92 (1998) 645-656
29. Tascilar M., Skinner H.G., Rosty C., Sohn T., Wilentz R.E., Offerhaus G.J., Adsay V., Abrams R.A., Cameron J.L., Kern S.E., Yeo C.J., Hruban R.H., and Goggins M. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 7 (2001) 4115-4121
30. Thiagalingam S., Lengauer C., Leach F.S., Schutte M., Hahn S.A., Overhauser J., Willson J.K., Markowitz S., Hamilton S.R., Kern S.E., Kinzler K.W., and Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 13 (1996) 343-346
31. Tsushima H., Kawata S., Tamura S., Ito N., Shirai Y., Kiso S., Imai Y., Shimomukai H., Nomura Y., Matsuda Y., and Matsuzawa Y. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110 (1996) 375-382
32. Wang J., Han W., Zborowska E., Liang J., Wang X., Willson J.K., Sun L., and Brattain M.G. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem. 271 (1996) 17366-17371
33. Wieser R. The transforming growth factor-beta signaling pathway in tumorigenesis. Curr. Opin. Oncol. 13 (2001) 70-77
34. Yu L., Hebert M.C., and Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21 (2002) 3749-3759
35. Zhang Y., Musci T., and Derynck R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr. Biol. 7 (1997) 270-276